XWELL Inc XWEL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.07
- Day Range
- $1.10–1.11
- 52-Week Range
- $0.27–2.20
- Bid/Ask
- $1.11 / $1.13
- Shares Outstanding
- 7.93M
- Market Cap
- $9.29M
- Volume/Avg
- 9,725 / 145,257
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.23
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
XWELL Inc is an international wellness organization dedicated to delivering restorative and health-focused services to travelers through its three reportable operating segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment, which generates maximum revenue, operates spa service locations in airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program. The Naples Wax Center segment operates six locations offering face and body waxing, skincare services, and cosmetic products. The Company generates maximum revenue from the United States.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 280
- Website
- https://www.xwell.com
Valuation
|
Metric
|
XWEL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 21.80 |
Price/Sales | 0.23 |
Price/Cash Flow | — |
Price/Earnings
XWEL
Financial Strength
|
Metric
|
XWEL
|
|---|---|
Quick Ratio | 2.16 |
Current Ratio | 2.35 |
Interest Coverage | — |
Quick Ratio
XWEL
Profitability
|
Metric
|
XWEL
|
|---|---|
Return on Assets (Normalized) | −26.10% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −49.38% |
Return on Assets
XWEL
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|#BLmw!Z | LOCK|L>? | $195B | |||
| Danaher Corp
DHR
| LOCK|m!Y$pj< | LOCK|th | $126B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|TM$ZVG#Q | LOCK|<f | $44B | |||
| Agilent Technologies Inc
A
| LOCK|<>n^w&& | LOCK|Q$ | $38B | |||
| Waters Corp
WAT
| LOCK|ZxV&xX | LOCK|MSd | $36B | |||
| IQVIA Holdings Inc
IQV
| LOCK|?N@c@M% | LOCK|c#zNq | $34B | |||
| Illumina Inc
ILMN
| LOCK|!DpPmRK | LOCK|<X$zT | $29B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|^$tKB?Q | LOCK|^JXN> | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|^H<??x@q | LOCK|q!@MT | $23B | |||
| Quest Diagnostics Inc
DGX
| LOCK|<r#J&w | LOCK|$Xw$ | $23B |
United States